nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—SLC6A3—bipolar disorder	0.788	1	CbGaD
Lisdexamfetamine—SLC6A2—locus ceruleus—bipolar disorder	0.0181	0.236	CbGeAlD
Lisdexamfetamine—SLC18A2—telencephalic ventricle—bipolar disorder	0.0141	0.183	CbGeAlD
Lisdexamfetamine—SLC6A3—telencephalic ventricle—bipolar disorder	0.0107	0.139	CbGeAlD
Lisdexamfetamine—SLC6A2—autonomic nervous system—bipolar disorder	0.00964	0.125	CbGeAlD
Lisdexamfetamine—SLC18A2—blood plasma—bipolar disorder	0.00672	0.0874	CbGeAlD
Lisdexamfetamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—CPLX1—bipolar disorder	0.00665	0.051	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Dopamine Neurotransmitter Release Cycle—CPLX1—bipolar disorder	0.00665	0.051	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Synaptic Vesicle Pathway—CPLX2—bipolar disorder	0.00527	0.0405	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Clearance of dopamine—COMT—bipolar disorder	0.00515	0.0396	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Clearance of dopamine—MAOA—bipolar disorder	0.00512	0.0393	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neurotransmitter Release Cycle—CPLX1—bipolar disorder	0.00337	0.0259	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Synaptic Vesicle Pathway—CPLX1—bipolar disorder	0.00289	0.0222	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Dopamine Neurotransmitter Release Cycle—SNAP25—bipolar disorder	0.00272	0.0209	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—SNAP25—bipolar disorder	0.00272	0.0209	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—thyroid gland—bipolar disorder	0.00238	0.0309	CbGeAlD
Lisdexamfetamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—bipolar disorder	0.00235	0.0181	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—bipolar disorder	0.00233	0.0179	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD3—bipolar disorder	0.00233	0.0179	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—bipolar disorder	0.00232	0.0178	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD4—bipolar disorder	0.00226	0.0174	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—ADCY2—bipolar disorder	0.00213	0.0163	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD2—bipolar disorder	0.00211	0.0162	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—MAOA—bipolar disorder	0.00205	0.0157	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—nervous system—bipolar disorder	0.00202	0.0263	CbGeAlD
Lisdexamfetamine—SLC18A2—nervous system—bipolar disorder	0.002	0.026	CbGeAlD
Lisdexamfetamine—SLC18A2—cerebellum—bipolar disorder	0.00188	0.0245	CbGeAlD
Lisdexamfetamine—SLC18A2—Neurotransmitter Release Cycle—GAD1—bipolar disorder	0.00186	0.0143	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Dopaminergic Neurogenesis—SLC6A3—bipolar disorder	0.00161	0.0124	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Amine compound SLC transporters—SLC6A3—bipolar disorder	0.00161	0.0124	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—bipolar disorder	0.00156	0.012	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—DRD5—bipolar disorder	0.00154	0.0119	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—brain—bipolar disorder	0.00154	0.0201	CbGeAlD
Lisdexamfetamine—SLC18A2—brain—bipolar disorder	0.00153	0.0199	CbGeAlD
Lisdexamfetamine—SLC6A3—nervous system—bipolar disorder	0.00151	0.0197	CbGeAlD
Lisdexamfetamine—SLC6A2—Monoamine Transport—TPH2—bipolar disorder	0.00145	0.0111	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—cerebellum—bipolar disorder	0.00142	0.0185	CbGeAlD
Lisdexamfetamine—SLC18A2—Neurotransmitter Release Cycle—SNAP25—bipolar disorder	0.00138	0.0106	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—DRD5—bipolar disorder	0.0013	0.00997	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Monoamine Transport—TPH2—bipolar disorder	0.00128	0.00983	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.00126	0.00964	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—nervous system—bipolar disorder	0.00122	0.0159	CbGeAlD
Lisdexamfetamine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—bipolar disorder	0.00118	0.00908	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Synaptic Vesicle Pathway—SNAP25—bipolar disorder	0.00118	0.00908	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—brain—bipolar disorder	0.00116	0.015	CbGeAlD
Lisdexamfetamine—SLC6A2—Monoamine Transport—SLC6A4—bipolar disorder	0.00116	0.00887	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Amine compound SLC transporters—SLC6A3—bipolar disorder	0.00108	0.00833	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neurotransmitter Release Cycle—MAOA—bipolar disorder	0.00104	0.00798	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Monoamine Transport—SLC6A3—bipolar disorder	0.00103	0.00791	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Monoamine Transport—SLC6A4—bipolar disorder	0.00102	0.00786	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—CPLX1—bipolar disorder	0.000968	0.00744	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—brain—bipolar disorder	0.000932	0.0121	CbGeAlD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR1A—bipolar disorder	0.000901	0.00692	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR2C—bipolar disorder	0.00087	0.00668	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—DRD1—bipolar disorder	0.00087	0.00668	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.000845	0.00649	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—DRD3—bipolar disorder	0.000842	0.00647	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—DRD4—bipolar disorder	0.000818	0.00628	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—DRD2—bipolar disorder	0.000762	0.00585	CbGpPWpGaD
Lisdexamfetamine—Selegiline—MAOA—bipolar disorder	0.000758	0.154	CrCbGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.000757	0.00581	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.000749	0.00575	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—bipolar disorder	0.000748	0.00575	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—CPLX1—bipolar disorder	0.000742	0.0057	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.000731	0.00561	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—DRD1—bipolar disorder	0.000731	0.00561	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—DRD3—bipolar disorder	0.000708	0.00544	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—DRD4—bipolar disorder	0.000687	0.00528	CbGpPWpGaD
Lisdexamfetamine—Dextroamphetamine—SLC6A3—bipolar disorder	0.000674	0.137	CrCbGaD
Lisdexamfetamine—Phenelzine—MAOA—bipolar disorder	0.000668	0.136	CrCbGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—DRD2—bipolar disorder	0.00064	0.00492	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.00063	0.00484	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—SLC5A3—bipolar disorder	0.000609	0.00468	CbGpPWpGaD
Lisdexamfetamine—Methamphetamine—MAOA—bipolar disorder	0.000584	0.119	CrCbGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—CPLX1—bipolar disorder	0.000577	0.00443	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.00057	0.00438	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.000556	0.00427	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.000544	0.00418	CbGpPWpGaD
Lisdexamfetamine—Amphetamine—SLC6A3—bipolar disorder	0.000543	0.11	CrCbGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—SLC5A3—bipolar disorder	0.00054	0.00414	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Monoamine GPCRs—HTR2A—bipolar disorder	0.000534	0.0041	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.000533	0.00409	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000505	0.00388	CbGpPWpGaD
Lisdexamfetamine—Methamphetamine—SLC6A3—bipolar disorder	0.000504	0.102	CrCbGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.000496	0.00381	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—RGS4—bipolar disorder	0.000453	0.00348	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—ADCY2—bipolar disorder	0.000453	0.00348	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.000448	0.00344	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CPLX1—bipolar disorder	0.000442	0.0034	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—GRIK2—bipolar disorder	0.000426	0.00327	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—bipolar disorder	0.000424	0.00326	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—DGKH—bipolar disorder	0.000421	0.00324	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Monoamine Transport—IL1B—bipolar disorder	0.00042	0.00323	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—GRIN1—bipolar disorder	0.000417	0.0032	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—GAD1—bipolar disorder	0.000409	0.00314	CbGpPWpGaD
Lisdexamfetamine—Amphetamine—SLC6A4—bipolar disorder	0.000406	0.0826	CrCbGaD
Lisdexamfetamine—Amphetamine—DRD2—bipolar disorder	0.000404	0.0822	CrCbGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—SERPINA1—bipolar disorder	0.000403	0.0031	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.000396	0.00304	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.000384	0.00295	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—CACNB2—bipolar disorder	0.00038	0.00292	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.000377	0.0029	CbGpPWpGaD
Lisdexamfetamine—Methamphetamine—SLC6A4—bipolar disorder	0.000377	0.0766	CrCbGaD
Lisdexamfetamine—SLC6A3—Monoamine Transport—IL1B—bipolar disorder	0.000372	0.00286	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.000358	0.00275	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—SERPINA1—bipolar disorder	0.000357	0.00274	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—SLC6A3—bipolar disorder	0.000353	0.00271	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.000351	0.00269	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—SLC6A4—bipolar disorder	0.000343	0.00263	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—SLC-mediated transmembrane transport—SLC5A3—bipolar disorder	0.00034	0.00261	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00034	0.00261	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—GRIK2—bipolar disorder	0.000332	0.00255	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—GRIN1—bipolar disorder	0.000324	0.00249	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—GAD1—bipolar disorder	0.000318	0.00244	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—SLC6A3—bipolar disorder	0.000306	0.00235	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—SLC6A4—bipolar disorder	0.000304	0.00233	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—SNAP25—bipolar disorder	0.000304	0.00233	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.000301	0.00231	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—COMT—bipolar disorder	0.0003	0.00231	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.000298	0.00229	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.000298	0.00229	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.000298	0.00229	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—CACNB2—bipolar disorder	0.000296	0.00227	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—TRPC3—bipolar disorder	0.000292	0.00224	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00029	0.00223	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.000286	0.0022	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—GRIN2B—bipolar disorder	0.000275	0.00211	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—TACR1—bipolar disorder	0.000272	0.00209	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—SLC6A3—bipolar disorder	0.000271	0.00208	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—ADCY2—bipolar disorder	0.000269	0.00206	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.000261	0.00201	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.000255	0.00196	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIK2—bipolar disorder	0.000254	0.00195	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—LPA receptor mediated events—GSK3B—bipolar disorder	0.000253	0.00194	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIN1—bipolar disorder	0.000249	0.00191	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GAD1—bipolar disorder	0.000244	0.00187	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.000243	0.00187	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—SNAP25—bipolar disorder	0.000236	0.00181	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—NRF2 pathway—NRG1—bipolar disorder	0.000233	0.00179	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00023	0.00177	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—COMT—bipolar disorder	0.00023	0.00177	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Neuronal System—MAOA—bipolar disorder	0.000228	0.00175	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—CACNB2—bipolar disorder	0.000226	0.00174	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—TAC1—bipolar disorder	0.000221	0.0017	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00022	0.00169	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—HTR2C—bipolar disorder	0.000217	0.00167	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—GRIN2B—bipolar disorder	0.000214	0.00164	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—ADCY2—bipolar disorder	0.000209	0.00161	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—NRF2 pathway—NRG1—bipolar disorder	0.000207	0.00159	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.000198	0.00152	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000195	0.0015	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD5—bipolar disorder	0.000194	0.00149	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.000194	0.00149	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—bipolar disorder	0.000193	0.00148	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—SNAP25—bipolar disorder	0.000181	0.00139	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00018	0.00138	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00018	0.00138	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—COMT—bipolar disorder	0.000179	0.00137	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmission across Chemical Synapses—MAOA—bipolar disorder	0.000178	0.00137	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.000174	0.00133	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000173	0.00133	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.000168	0.00129	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.000168	0.00129	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—GRIN2B—bipolar disorder	0.000164	0.00126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.000163	0.00125	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—ADCY2—bipolar disorder	0.00016	0.00123	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.000158	0.00121	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.000149	0.00114	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000148	0.00114	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.000147	0.00113	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.000147	0.00113	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000146	0.00112	CbGpPWpGaD
Lisdexamfetamine—SLC18A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000144	0.00111	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.000144	0.0011	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.000144	0.0011	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—ADM—bipolar disorder	0.000141	0.00108	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.000139	0.00107	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—COMT—bipolar disorder	0.000137	0.00105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—TSHB—bipolar disorder	0.000137	0.00105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—TACR1—bipolar disorder	0.000137	0.00105	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Neuronal System—MAOA—bipolar disorder	0.000136	0.00105	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.000135	0.00104	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—G alpha (q) signalling events—HTR2A—bipolar disorder	0.000133	0.00102	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000131	0.00101	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.000126	0.000967	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DGKH—bipolar disorder	0.00012	0.000923	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.000119	0.000915	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR1A—bipolar disorder	0.000113	0.000871	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—TAC1—bipolar disorder	0.000112	0.000858	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD5—bipolar disorder	0.00011	0.000844	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD1—bipolar disorder	0.00011	0.000841	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2C—bipolar disorder	0.00011	0.000841	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DGKH—bipolar disorder	0.000109	0.000838	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—RGS4—bipolar disorder	0.000108	0.000827	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD3—bipolar disorder	0.000106	0.000814	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.000103	0.000791	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD4—bipolar disorder	0.000103	0.000791	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD5—bipolar disorder	9.98e-05	0.000766	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	9.79e-05	0.000752	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—RGS4—bipolar disorder	9.78e-05	0.000751	CbGpPWpGaD
Lisdexamfetamine—SLC6A2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	9.72e-05	0.000747	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—DRD2—bipolar disorder	9.59e-05	0.000737	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	8.82e-05	0.000677	CbGpPWpGaD
Lisdexamfetamine—SLC6A3—Transmembrane transport of small molecules—ADCY2—bipolar disorder	8.61e-05	0.000661	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TRPC3—bipolar disorder	8.33e-05	0.000639	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADM—bipolar disorder	7.94e-05	0.00061	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TSHB—bipolar disorder	7.74e-05	0.000594	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—PDE4B—bipolar disorder	7.74e-05	0.000594	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TACR1—bipolar disorder	7.74e-05	0.000594	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TRPC3—bipolar disorder	7.56e-05	0.000581	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADM—bipolar disorder	7.21e-05	0.000554	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	7.05e-05	0.000541	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TSHB—bipolar disorder	7.03e-05	0.00054	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—PDE4B—bipolar disorder	7.03e-05	0.00054	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TACR1—bipolar disorder	7.03e-05	0.00054	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—AKR1C4—bipolar disorder	7e-05	0.000538	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—HTR2A—bipolar disorder	6.72e-05	0.000516	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DGKH—bipolar disorder	6.44e-05	0.000495	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR1A—bipolar disorder	6.41e-05	0.000492	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—TAC1—bipolar disorder	6.31e-05	0.000485	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2C—bipolar disorder	6.19e-05	0.000475	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD1—bipolar disorder	6.19e-05	0.000475	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD3—bipolar disorder	5.99e-05	0.00046	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD5—bipolar disorder	5.89e-05	0.000453	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR1A—bipolar disorder	5.82e-05	0.000447	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD4—bipolar disorder	5.82e-05	0.000447	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—RGS4—bipolar disorder	5.78e-05	0.000444	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—TAC1—bipolar disorder	5.73e-05	0.00044	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2C—bipolar disorder	5.62e-05	0.000432	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD1—bipolar disorder	5.62e-05	0.000432	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—ADCY2—bipolar disorder	5.48e-05	0.000421	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD3—bipolar disorder	5.44e-05	0.000418	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—DRD2—bipolar disorder	5.42e-05	0.000416	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR ligand binding—POMC—bipolar disorder	5.36e-05	0.000412	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD4—bipolar disorder	5.28e-05	0.000406	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—ADCY2—bipolar disorder	4.97e-05	0.000382	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—DRD2—bipolar disorder	4.92e-05	0.000378	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TRPC3—bipolar disorder	4.47e-05	0.000343	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADM—bipolar disorder	4.26e-05	0.000327	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—PDE4B—bipolar disorder	4.15e-05	0.000319	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TSHB—bipolar disorder	4.15e-05	0.000319	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TACR1—bipolar disorder	4.15e-05	0.000319	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—HTR2A—bipolar disorder	3.8e-05	0.000292	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—HTR2A—bipolar disorder	3.45e-05	0.000265	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR1A—bipolar disorder	3.44e-05	0.000264	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TAC1—bipolar disorder	3.39e-05	0.00026	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD1—bipolar disorder	3.32e-05	0.000255	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2C—bipolar disorder	3.32e-05	0.000255	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NTRK2—bipolar disorder	3.23e-05	0.000248	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD3—bipolar disorder	3.22e-05	0.000247	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GSK3A—bipolar disorder	3.2e-05	0.000246	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD4—bipolar disorder	3.12e-05	0.00024	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—GPCR downstream signaling—POMC—bipolar disorder	3.03e-05	0.000233	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—ADCY2—bipolar disorder	2.94e-05	0.000226	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—TCF7L2—bipolar disorder	2.93e-05	0.000225	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	2.91e-05	0.000223	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	2.75e-05	0.000211	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	2.63e-05	0.000202	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—S100B—bipolar disorder	2.56e-05	0.000197	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	2.26e-05	0.000173	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	2.04e-05	0.000156	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	1.64e-05	0.000126	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—POMC—bipolar disorder	1.63e-05	0.000125	CbGpPWpGaD
Lisdexamfetamine—ADRA1B—Signaling Pathways—INS—bipolar disorder	1.62e-05	0.000124	CbGpPWpGaD
